- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01887730
Hand Hygiene Intervention Study in Finnish Garrison (VirusFight)
August 23, 2018 updated by: Finnish Institute for Health and Welfare
Can Intensified Hand Hygiene Decrease Morbidity and Lost Service Days in a Garrison
In this study the investigators aim to elucidate the possibility to reduce occurrence of infectious diseases in a garrison with enhanced and guided hand hygiene.
The investigators will study occurrence and transmission of infections.
In addition, the investigators will find out the causative agents of infections in a garrison with virological analyses of naso-pharyngeal and fecal specimens.
The costs of lost service days and other expenses due to infectious diseases will be evaluated with a cost analysis study.
Study Overview
Status
Suspended
Conditions
Study Type
Interventional
Enrollment (Actual)
1120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kouvola, Finland, 46140
- Vekaranjärvi garrison
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- willingness to attend to the study
Exclusion Criteria:
- skin diseases which prevent using hand disinfectants
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: arm 2
Hand washing with soap and water according to instructions.
The effect of intervention is assessed by following occurrence of infections.
|
Can infections be prevented by hand washing with soap and water
|
Placebo Comparator: arm 0
No specific advice on hand hygiene.
The effect of intervention is assessed by following occurrence of infections.
|
|
Active Comparator: Arm 3
Hand cleaning with alcohol-containing hand rub
|
Can infections be prevented by hand cleaning with alcohol-containing hand rub.
Effect of intervention is assessed by following occurrence of infections
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of infection episodes during basic training period. The periods when a person has been in duty in spite of the infection will be included.
Time Frame: 8 weeks
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Length of distinct infection episodes due to infectious disease
Time Frame: 8 weeks
|
8 weeks
|
Length of distinct absence episodes due to infectious disease.
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Carita Savolainen-Kopra, Finnish Institute for Health and Welfare
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
September 1, 2013
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
June 19, 2013
First Submitted That Met QC Criteria
June 24, 2013
First Posted (Estimate)
June 27, 2013
Study Record Updates
Last Update Posted (Actual)
August 27, 2018
Last Update Submitted That Met QC Criteria
August 23, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- THL/81/6.05.00/2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infections
-
International Centre for Diarrhoeal Disease Research...Centers for Disease Control and PreventionNot yet recruitingMeasles | Rubella | Cholera | Typhoid
-
MJM BontenJanssen Research & Development, LLC; Innovative Medicines InitiativeCompletedE.Coli InfectionsUnited States, United Kingdom, Canada, France, Germany, Italy, Japan, Spain
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedInfections, MeningococcalGermany, France
-
GlaxoSmithKlineCompletedInfections, MeningococcalGermany
-
GlaxoSmithKlineCompletedInfections, MeningococcalKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, MeningococcalUnited States
-
University of ZurichUnknownEscherichia Coli InfectionsSwitzerland
-
GlaxoSmithKlineCompletedInfections, MeningococcalUnited States
-
GlaxoSmithKlineCompletedInfections, MeningococcalLebanon
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted